Kelly Lau

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A

Brian Long, P. Véron, Klaudia Kuranda et al. · Molecular Therapy · 2020 · 71 citations · Full text

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials

Soumi Gupta, Kelly Lau, Cary O. Harding et al. · EBioMedicine · 2018 · 69 citations · Full text

Immunogenicity of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients With Morquio A Syndrome: Results From MOR-004, a Phase III Trial

Becky Schweighardt, Troy Tompkins, Kelly Lau et al. · Clinical Therapeutics · 2014 · 55 citations

Elosulfase Alfa, Autoimmune Disease, Allergy +8

Diagnostic clues to megaloblastic anaemia without macrocytosis

Clement Wn Chan, S. Y. H. LIU, Chi Shan Kho et al. · International Journal of Laboratory Hematology · 2007 · 37 citations

Immunohematology, Iron Metabolism, Diagnosis +19

Long-term safety and efficacy of pegvaliase for the treatment of phenylketonuria in adults: combined phase 2 outcomes through PAL-003 extension study

Nicola Longo, Roberto T. Zori, Melissa Wasserstein et al. · Orphanet Journal of Rare Diseases · 2018 · 31 citations · Full text